Table 1 Correlation between CASC9 expression and ESCC clinical parameters
Clinical parameters | Low expression | High expression | P valuea |
---|---|---|---|
N = 57 | N = 58 | ||
Age (years) | Â | Â | Â |
 <60 | 32 | 33 | 0.935 |
 >60 | 25 | 25 | |
Gender | Â | Â | Â |
 Male | 43 | 44 | 0.786 |
 Female | 14 | 14 | |
Differentiation grade | Â | Â | Â |
 Well/moderate | 52 | 47 | 0.114 |
 Poor | 5 | 11 | |
Primary tumor invasion depth | Â | Â | Â |
 T1/T2 | 39 | 26 | 0.011* |
 T3/T4 | 18 | 32 | |
Lymph node metastasis | Â | Â | Â |
 Negative | 47 | 27 | <0.01** |
 Positive | 10 | 31 | |
TNM stage | Â | Â | Â |
 I/II | 50 | 35 | 0.001** |
 III/IV | 7 | 23 | |
Smoking | Â | Â | Â |
 Yes | 35 | 38 | 0.558 |
 No | 22 | 20 | |
Drinking | Â | Â | Â |
 Yes | 34 | 37 | 0.648 |
 No | 23 | 21 |